Somnigroup International Inc. SGI
Composite 44/100; the shares have moved about 46% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Momentum ranks 27/100 — a moderate mark against it.
Growth ranks 62/100 — a moderate point in its favour. Quality ranks 52/100 — a slight point in its favour.
Momentum ranks 27/100 — a moderate mark against it. Balance-sheet strength ranks 32/100 — a moderate mark against it. Income ranks 44/100 — a slight mark against it.
What the company does Somnigroup International Inc. (SGI) designs, manufactures, and retails bedding products under brands like Tempur-Pedic, Sealy, Stearns & Foster, and Sleepy's. It operates retail stores (Mattress Firm, Dreams) and licenses brands to third-party manufacturers. SGI sells through stores, online, and third-party retailers, serving residential and commercial markets globally.
Key financials SGI’s profitability metrics include ROE 17.7%, ROA 5.6%, and ROCE 9.4%. Margins stand at gross 44.6%, operating 10.6%, and net 6.8%. Revenue grew 12.3% YoY, while EPS surged 62.4%. Debt/Equity is 2.07, with net debt/EBITDA at 5.06 and interest coverage of 3.50.
Stock health The stock shows weak momentum, down -25.15% over 6 months and -31.84% from its 52-week high. Sideravia’s Overall score is 48.9 (average quality, fairly valued), with Momentum at 29.2. The RSI(14) is 37.60, indicating oversold conditions.
Price vs fair value SGI trades at a PREMIUM of 67.40% versus our fair-value estimate of 21.80 and at a discount of 45.06% to the 12-month target of 97.00. - Analysts highlight potential earnings growth ahead of next week’s report (Zacks). - Caution is advised by StockStory, flagging three favored stocks with risks (StockStory). - High valuation metrics (P/E 29.16, EV/EBITDA 18.10) may limit upside.
Looking forward Forward P/E of 22.47 and PEG of 0.75 suggest moderate growth expectations. Revenue and EPS growth trends are positive, but leverage (Debt/Equity 2.07) and weak momentum warrant monitoring. Near-term catalysts include earnings results and brand performance.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.